Center for Excellence in Eye Care

Miami, Florida 33176

1 studies enrolling now · 19 studies all time

What they study most

Aphakia, Bacterial Infections, Blepharitis, Blepharoplasty, Cataract, Cataract Extraction, Conjunctivitis, Dry Eye, Dry Eye Disease, Dry Eye Syndromes, Ectasia, Endocrine System Diseases

Studies at this site

• Evaluating Patient Reported Outcomes and Surgeon Satisfaction With Ziplyft™ — Recruiting now
• Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus — Completed
• Randomized Study of the Safety and Effectiveness of the TearCare System for the Signs and Symptoms of Dry Eye Disease — Stopped early
• Clinical Study Evaluating Nordlys™ SWT IPL for Dry Eye Disease (DED) Due to MGD — Running, not enrolling
• A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) — Running, not enrolling
• RPS InflammaDry Detector™ to Determine MMP-9 Levels in Tears — Completed
• A Comparison of the RPS Adeno Detector IV to Viral Cell Culture at Detecting Adenoviral Conjunctivitis — Completed
• Corneal Collagen Cross-linking for Progressive Keratoconus — Completed
• Corneal Collagen Cross-Linking for Ectasia (CXL) — Completed
• CXL-04 A Study of Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas — Stopped early
• Ultraviolet-A and Riboflavin Treatment for Infectious Keratitis — Completed
• Comparison of the Hoya Surgical Optics (HSO) iSert 251 Posterior Chamber Aspheric Aphakic Intraocular Lens to Historical / Literature Controls. — Completed
• Randomized Controlled Trial of Long-term Treatment Effectiveness for Meibomian Gland Dysfunction (MGD) and Dry Eye — Completed
• The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Four-Week Treatment Period (P08638) — Completed
• Safety and Efficacy Pilot Study of AzaSite® (Azithromycin) in Subjects With Blepharitis — Completed
• Study of AzaSite Versus Vigamox Concentrations in the Conjunctiva and Aqueous Humor in Subjects Undergoing Routine Cataract Surgery — Completed
• DY001: Safety and Effectiveness of DYME as an Agent for Selective Staining of the Anterior Capsule During Cataract Surgery — Completed
• DY002: Safety and Effectiveness of DYME as an Agent for Selective Staining of the Anterior Capsule During Cataract Surgery — Stopped early
• Safety and Efficacy Assessment of Vismed® (Sodium Hyaluronate) for the Treatment of Dry Eye Syndrome — Completed